| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Cardiovascular Research Institute and Department of Medical Physiology, Texas A&M University System Health Science Center, College Station, Texas 77843-1114; 2 Department of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky 40292; and 3 Department of Human Biology and Movement Science, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3083, Australia
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Microtubules are important cytoskeletal elements that have been shown to play a major role in many cellular processes because of their mechanical properties and/or their participation in various cell signaling pathways. We tested the hypothesis that depolymerization of microtubules would alter vascular smooth muscle (VSM) tone and hence contractile function. In our studies, isolated cremaster arterioles exhibited significant vasoconstriction that developed over a 20- to 40-min period when they were treated with microtubule depolymerizing drugs colchicine (10 µM), nocodazole (10 µM), or demecolcine (10 µM). Immunofluorescent labeling of microtubules in cultured rat VSM revealed that both colchicine and nocodazole caused microtubule depolymerization over a similar time course. The vasoconstriction was maintained over a wide range of intraluminal pressures (30-170 cmH2O). The increased tone was not affected by endothelial denudation, suggesting that it was due to an effect on VSM. Microtubule depolymerization with demecolcine or colchicine had no effect on VSM intracellular Ca2+ concentration ([Ca2+]i). These data indicate that microtubules significantly interact with processes leading to the expression of vasomotor tone. The mechanism responsible for the effect of microtubules on vasomotor tone appears to be independent of both the endothelium and an increase in VSM [Ca2+]i.
cytoskeleton; tubulin; vascular smooth muscle; endothelium; vasoconstriction; microcirculation
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
MICROTUBULES ARE dynamic protein polymers that,
together with actin filaments and intermediate filaments, compose the
cytoskeleton. Many cellular processes are regulated or modulated by
microtubules. These include mitosis, locomotion, protein and organelle
transport, protein and organelle organization and sorting and
translational control of mRNA (1, 12, 19). In addition, microtubules have been shown to interact with several cell signaling pathways linked
to adenylate cyclase (14), phospholipase
C
1 (PLC; see Ref. 13), and
phosphorylation of 20-kDa myosin light chain (9) and are an important
determinant of a cell's mechanical properties (7, 8). Because of the
involvement of microtubules in these cellular functions and the
mechanical characteristics of microtubules, we hypothesized that
depolymerization of microtubules would alter vascular smooth muscle
(VSM) contractile function and hence vasomotor tone.
Recently, evidence has suggested that microtubules can affect the contractile process in several cell types. These include fibroblasts (9, 3), cardiac myocytes (16), and VSM of large- and intermediate-sized arteries (2, 10, 15). Despite this emerging evidence, the mechanisms and the physiological implications of these observations have not been established. An important goal of this study was to characterize the vasomotor effects associated with altering the state of microtubule polymerization in intact, isolated resistance arterioles. Additionally, we investigated several possible mechanisms, including the endothelium, VSM intracellular Ca2+ concentration ([Ca2+]i), and neurotransmitter release from adrenergic nerve terminals by which microtubules might modulate vasomotor tone.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Isolated Vessel Preparation
Male Sprague-Dawley rats (250-350 g) were anesthetized with an intraperitoneal injection of pentobarbital sodium (100 mg/kg). Anesthesia was confirmed by the loss of spinal reflexes. One cremaster muscle was carefully removed and placed in a refrigerated (4°C) lexan chamber filled with physiological saline solution (PSS) containing (in mM) 145 NaCl, 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, 1.0 NaH2PO4, 5.0 dextrose, 2.0 pyruvate, 0.02 EDTA, 3.0 MOPS, and 0.15 albumin. A first-order segment of the cremaster feed arteriole was isolated, removed, and placed in a separate bathing chamber. The vessel bath chamber was filled with a HCO
3-buffered PSS containing (in mM)
110 NaCl, 5 KCl, 3 CaCl2, 1 MgSO4, 1 KH2PO4, 10 dextrose, and 30 NaHCO3 that
was equilibrated with 5% CO2-95% N2. This chamber was fitted with
pipette holders, and the entire apparatus was mounted on an inverted
microscope stage plate. Isolated arterioles were cannulated with two
glass micropipettes (80- to 100-µm OD). The proximal end of the
arteriole was tied to an open pipette using 12-0 nylon suture, and
any red blood cells were flushed from the lumen by application of
gentle positive pressure (
20
cmH2O). The distal end of the
vessel was then cannulated and tied to a closed micropipette. The
vessel-mounting apparatus was transferred to the stage of an inverted
microscope (Zeiss IM35) and was slowly warmed to 34.5°C. Arterioles
were pressurized to 90 cmH2O by
adjusting the height of a water reservoir and were checked for leaks by
turning off the pressure head for 30 s. Any vessels that showed a
decrease in diameter were discarded. At the conclusion of each
experiment, adenosine (104
M) was added in a Ca2+-free PSS
containing 4 mM EGTA to obtain passive diameter at 90 cmH2O. Lumen diameters were
recorded on-line using a video monitor coupled to a video caliper
system (5). Myogenic responses were studied by exposing arterioles to
step changes in intravascular pressure
(20-cmH2O steps) over a range of
30-170 cmH2O. Diameter measurements were recorded for 4 min after each step to assure a
steady-state response.
Manipulation of Microtubule Network Structure
After we obtained a control pressure-diameter curve, arterioles were treated for 1 h with nocodazole (10 µM, n = 4), colchicine (10 µM, n = 8), or demecolcine (10 µM, n = 9) to disrupt microtubules. All three of these inhibitors bind to the colchicine-binding site on tubulin and prevent addition of tubulin to the microtubule, leading to a net loss of polymerized tubulin (18). A second pressure-diameter relationship was then acquired. Demecolcine was prepared as a 5 mM stock solution with water and was diluted to the appropriate concentration immediately before each experiment. All other microtubule-modulating drugs were prepared as concentrated stocks with DMSO and were diluted with PSS to the appropriate concentrations.Immunocytochemistry
Cells. To determine the effectiveness of the microtubule-depolymerizing agents, the microtubule network was examined in VSM after treatment with colchicine or nocodazole using fluorescent immunocytochemistry. VSM cells were enzymatically isolated from rat thoracic aorta. Briefly, aortic segments were stirred at 37°C for 45 min in an enzymatic solution containing (in mM) 118 NaCl, 6 KCl, 25 MOPS, 1.2 NaH2PO4, 1.2 MgSO4, 0.027 EDTA, 11 glucose, 2 dithiothreitol, and 2 mg/ml papain. After incubation, aortic segments were allowed to settle to the bottom of the vial, and the solution was carefully aspirated and replaced with culture media (DMEM). Vessel segments were then rapidly triturated with a heat-polished Pasteur pipette. Dissociated cells were centrifuged, resuspended in media, and plated at a density of 1 × 105 cells/ml. Cells were grown in DMEM supplemented with 10% FBS and 2% (vol/vol) antibiotic/antimycotic. At passage 4, the cells were treated with trypsin (0.1%) and replated on glass coverslips, where they were allowed to attach and spread for ~24 h. After colchicine treatment, the cells were fixed at 0, 15, 30, and 60 min with 2% paraformaldehyde and permeabilized with 0.2% Triton X-100. Cells were incubated with a mixture of monoclonal mouse anti-
-tubulin and anti--tubulin
antibodies followed by incubation with a goat anti-mouse secondary
antibody conjugated with FITC. Cells were visualized and imaged on a
Zeiss Axiovert 100 coupled to a CellScan Digital Imaging Microscopy
System (Scanalytics, Billerica, MA). All images were deconvolved to
remove nonfocused light.
Arterioles. Isolated arterioles were
incubated with nocodazole (10 µM, n = 2) for 60 min or vehicle (DMSO) as a control. After treatment,
vessels were fixed in 2% paraformaldehyde and permeabilized with cold
acetone (
20°C) for 1 min. All vessels were then incubated with a mixture of mouse FITC-conjugated anti--tubulin and
anti--tubulin for 90 min in a humidified tissue culture chamber.
Next, each arteriole was individually mounted on a glass microscope
slide using the ProLong anti-fade kit (Molecular Probes, Eugene, OR). Labeling and imaging of the treated vessels was performed on the same
day to minimize variations due to the labeling procedure. Vessels were
imaged with an Ultima-Z argon laser confocal scanning microscope
(Genomic Solutions, Lansing, MI). Fluorescent images were background
subtracted, and intensity measurements were performed by drawing
regions of interest in different sections of each vessel. The mean
fluorescent intensity (scale of 0-4,095) was calculated and
normalized to control vessels to allow for comparison between vessels.
-Adrenergic Blockade
-adrenergic nerve terminals in the arteriolar wall. Vessels
were pretreated with phentolamine for 20 min and then were subjected to
the colchicine treatment protocol.
Endothelium Denudation
To test for the possible involvement of the endothelium, pressure-diameter relationships were acquired from colchicine-treated vessels before and after the endothelium was mechanically removed (n = 6). Denudation was performed by physically rubbing the intraluminal surface with an abrasive micropipette. Previous work in our laboratory has shown that this type of endothelial denudation has no effect on resting vascular tone (4). The absence of a functional endothelium was confirmed by the lack of dilation to ACh (1 µM).VSM Ca2+
To determine whether the vasoconstriction due to microtubule disruption was caused by increased [Ca2+]i, VSM [Ca2+]i was measured with the Ca2+-sensitive fluorescent indicator fura 2-AM (Molecular Probes) using previously described techniques (11). After equilibration, vessels were abluminally incubated with a suspension of fura 2-AM (2-5 µM), DMSO (0.5%), and pluronic F-127 (0.01%) in normal PSS for ~1 h. After being loaded with fura 2, the vessel was washed with fresh PSS and equilibrated for at least 30 min. Fura 2 fluorescence emissions were measured at 510 nm during excitations at 340 and 380 nm. The ratio of fura 2 fluorescence at 340 to 380 nm is directly proportional to [Ca2+]i (6). In these experiments, the 340- to 380-nm ratio was determined before and after treatment with demecolcine (10 µM, n = 3) or colchicine (1.25 × 105 M,
n = 8). A test dose of norepinephrine
(5 mM) was applied at the beginning and end of each
Ca2+ measurement experiment to
verify the ability of the Ca2+
measurement system to detect changes in
Ca2+.
Data Analysis and Statistics
Data were normalized to passive diameter at 90 cmH2O and are expressed as means ± SE. Arteriolar responses were analyzed using ANOVA followed with either Dunnett's test or Fisher's protected least squares difference for multiple comparisons. Significance was defined with a probability <0.05.| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
All vessels studied gained spontaneous tone resulting in a reduction in
diameter to 50-70% of passive diameter. Mean arteriolar diameter
with spontaneous tone was 114 ± 4 µm at 90 cmH2O. Colchicine treatment
significantly increased vasomotor tone (33.9% constriction relative to
basal tone at 90 cmH2O) within
20-40 min as did all other microtubule-disrupting agents. Figure
1 shows the pressure-diameter curves before
and after treatment with
105 M colchicine as well as
the corresponding passive diameter curve. Using 90 cmH2O as a reference, the control
diameter in vessels with spontaneous tone was 70 ± 6% of passive
diameter. After treatment with colchicine, arterioles constricted to 48 ± 3% of passive diameter. This constriction was maintained over
the entire pressure range and was significantly different from both the
control diameter and the passive diameter. As shown in Fig.
2, nocodazole also caused significant
vasoconstriction of arterioles with spontaneous tone (29.6% at 90 cmH2O). Similarly, demecolcine
produced a significant vasoconstriction (32.7%) in vessels with
spontaneous tone (Fig. 3). Thus all of the
microtubule-depolymerizing drugs were found to affect spontaneous
vasomotor tone in a similar manner, reducing the possibility that the
constriction was due to a nonspecific action of the drug treatments.
|
|
|
Various concentrations of demecolcine (0.1-100 µM) were used to
obtain a concentration-response relationship
(n = 17). In addition, vessels
(n = 7) were treated with 10 µM
demecolcine, and diameter measurements were obtained throughout the
60-min incubation period to obtain a response time course. Figure
4A shows
the concentration-response relationship for demecolcine, in which
>90% of the vasoconstriction associated with demecolcine occurred
with a concentration of 10 µM. With this concentration of
demecolcine, vessels were observed to constrict throughout the 60-min
time period, reaching maximal levels of constriction between 40 and 60 min (Fig. 4B).
|
Microtubule disruption was confirmed with immunocytochemical
experiments. Both colchicine (10 µM) and nocodazole (10 µM) caused time-dependent disassembly of the tubulin cytoskeleton in cultured VSM
cells. Effects were seen as early as 15 min, and complete disruption
occurred between 30 and 60 min for colchicine and between 15 and 30 min
for nocodazole. Figure 5 shows
immunolabeled VSM cells exhibiting the typical time course for
microtubule disruption by colchicine. Isolated arterioles treated with
nocodazole (data not shown) also showed decreased microtubule density,
as indicated by a 45 ± 0.15% reduction in fluorescent intensity of
labeled microtubules compared with control. Thus the time course
observed for depolymerization of microtubules approximated the time
curve of the vasoconstrictor response (Fig.
4B).
|
To determine whether the vasoconstriction observed with the
depolymerizing agents was the result of release of a vasoactive endothelial factor, we mechanically removed the endothelium from six
vessels with an abrasive pipette. These vessels were then treated with
colchicine and were observed to undergo vasoconstriction in response to
colchicine similar to that of vessels with intact endothelium (Fig.
6).
|
Another group of vessels (n = 8) was
treated with phentolamine (1 µM) to antagonize -adrenergic
receptors. Phentolamine treatment had no effect on colchicine-induced
vasoconstriction (46.2 ± 3.3 vs. 44.3 ± 2.7% of passive
diameter), indicating that the constriction was not due to an effect of
microtubule depolymerization on adrenergic nerve terminal release of
norepinephrine. However, these experiments do not rule out the
possibility of release of a vasoactive cotransmitter.
To determine whether a change in VSM
[Ca2+]i
was involved in this vasoconstriction, isolated arterioles were
abluminally loaded with the
Ca2+-sensitive fluorescent dye
fura 2-AM (n = 11). The 340- to 380-nm ratio was used as a measure of VSM
[Ca2+]i.
Demecolcine-treated (10 µM, n = 3)
arterioles exhibited a time-dependent increase in vascular tone with no
concurrent change in [Ca
2+]i
(Fig. 7). Vessels
(n = 8) treated with colchicine (1.25 × 105 M) produced
similar results. After 1 h of incubation with colchicine, arterioles
had a 340- to 380-nm fura ratio of 1.7 ± 0.01, which was not
different from control vessels in which the ratio was 1.8 ± 0.11.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The purpose of this study was to test the hypothesis that the
depolymerization of microtubules would alter VSM contractile function
and thus the expression of vasomotor tone and vascular diameter. We
observed that three different microtubule-disrupting drugs caused a
significant vasoconstriction. Colchicine, nocodazole, and demecolcine
all caused significant arteriolar constrictions (33.9, 29.6, and 32.7%
relative to basal tone, respectively) that were not statistically
different from each other. We also confirmed that both colchicine (Fig.
5) and nocodazole (data not shown) caused complete disruption of the
microtubule network in cultured VSM cells over a time course similar to
that observed for the appearance of the vasoconstriction, suggesting
that the two events are correlated. This constriction was not
attributed to activation of -adrenergic nerve terminals in the
vascular wall, release of a vasoactive endothelial substance, or an
increase in VSM [Ca2+]i.
A role for microtubules in modulating contractile function has been previously shown in both nonmuscle and muscle cells. Danowski (3) and Kolodney and Elson (9) have independently demonstrated that fibroblasts contracted when microtubules were disrupted with demecolcine, vinblastine, and/or nocodazole. Both groups used in vitro assays of fibroblast contraction, but Danowski measured deformation (wrinkling) of a silicone substrate, whereas Kolodney and Elson measured isometric force generated from cells cultured within a collagen lattice. Additionally, they found that paclitaxel could reverse the contraction (2, 9). Thus they concluded that the modulation of contraction/force generation was microtubule dependent. In cardiac myocytes, Tsutsui et al. (16) showed that microtubule density was increased during pressure-induced cardiac hypertrophy and that observed contractile deficiency correlated with the increase in microtubule density. Cells treated with paclitaxel to increase microtubule density exhibited a similar degree of contractile deficiency. This dysfunction could be reversed by treatment with colchicine or cold, both of which depolymerize microtubules. It was concluded from their studies that microtubules impose a viscous intracellular load and that increasing microtubule density increased this viscous load, thus opposing myocyte contraction. Thus these studies support a role for microtubules/tubulin in modulating cellular contractile function.
Recently, several investigators have begun to examine the effect of
microtubule depolymerization on VSM contraction. Sheridan et al. (15)
showed that agonist-dependent contraction of rings from the pulmonary
artery was significantly increased after treatment with the
microtubule-depolymerizing agent vinblastine. Similarly, Leite and Webb
(10) observed an enhanced vasoconstriction to -adrenergic receptor
activation in mesenteric arteries treated with nocodazole. Another
study, in aortic VSM rings, showed that complete microtubule disruption
with colchicine and/or cold enhanced stretch-induced tension
development (2). Similarly, our results showed that microtubule
depolymerization enhanced development of vasomotor tone in pressurized
resistance arterioles. This increase in vasomotor tone was superimposed
on intrinsic spontaneous tone and was maintained throughout the
myogenic pressure range. However, it is premature to define this
augmented tone as myogenic in nature without a more detailed
understanding of the mechanism. It was also apparent in our studies
that the enhanced tone was not accompanied by augmented myogenic
responses to step changes in pressure. Collectively, the changes in
vasomotor tone and vascular reactivity reported by these studies
establish a clear link between microtubules/tubulin and the VSM
contractile process. However, the mechanism responsible for the
relationship between microtubules and the contractile process remains undefined.
Several mechanisms may be proposed to explain the ability of
microtubules to modulate contractile function. Generally, these can be
described as belonging to one of the following four groups: 1) those involving an effect on
nerve terminals within the vessel wall,
2) involvement of endothelial cell
vasoactive factor(s), 3) changes in
cellular signaling mechanisms, or 4)
mechanisms related to mechanical properties of the cytoskeleton. In our
study, phentolamine antagonism of -adrenergic receptors was without effect, indicating that norepinephrine release was not involved. This
observation does not, however, rule out the possibility that there may be release of a vasoconstrictive cotransmitter.
Removal of the endothelium did not have any effect on the vasoconstriction caused by microtubule depolymerization, suggesting that the endothelium is not essential in mediating this response. In mesenteric arteries, however, Leite and Webb (10) reported that nitric oxide synthase inhibition with NG-nitro-L-arginine potentiated pressor responses after nocodozole treatment. These differences point to possible tissue-specific differences and suggest that a modulatory role for the endothelium cannot be entirely dismissed.
Numerous chemical mediators have been proposed to account for the cellular effects related to the state of microtubule polymerization. Rasenick and Wang (14) have proposed that transduction of signals in neurons via adenylate cyclase may be mediated by tubulin monomers, which are proposed to interact with G proteins by virtue of their ability to reversibly bind GTP. More recently, Popova et al. (13) have shown that tubulin can regulate PLC activity. The regulation of PLC appears complex, as low cellular concentrations of tubulin activated PLC, whereas high concentrations inhibited PLC activity. An additional possibility was proposed by Kolodney and Elson (9). They showed that microtubule disruption in fibroblasts leads to increased phosphorylation of the myosin regulatory light chain. Although the mediator for this phosphorylation event was not identified, it could be related to regulation of [Ca2+]i. Collectively, phosphorylation of the myosin regulatory light chain and the adenylate cyclase and PLC signaling systems is known to be associated with regulation of the contractile apparatus and thus bears further investigation in VSM.
Because [Ca2+]i could be related to both phosphorylation of the myosin regulatory light chain and PLC activation, we examined the possibility that microtubule disruption could be related to regulation of VSM [Ca2+]i. Using the Ca2+-sensitive dye fura 2, we were unable to detect any change in cell [Ca2+]i after treatment with demecolcine or colchicine. This is in agreement with published data in cardiac myocytes (16) in which colchicine actually caused a small decrease in [Ca2+]i. The lack of a change in [Ca2+]i suggests that the putative involvement of the above signaling pathways in microtubule-induced contraction may be more complex in nature.
Perhaps the best-known theory incorporating and integrating the mechanical properties of the cytoskeleton with cellular function is the "tensegrity" theory of cellular architecture (7, 8). In this model, microtubules are a component of the cytoskeleton believed to act as compression-resistant elements within the cell. These elements are proposed to oppose the contractile "pull" of the actin cytoskeleton. On the basis of this model, it has been speculated that disrupting the microtubules (compression-resistant struts) would act to reduce the internal mechanical resistance to contraction. Thus the tension-generating elements (i.e., contractile apparatus) would be able to shorten more efficiently. This could translate into increased force generation and contraction of the cell. Consequently, this mechanism may also be a possible explanation for the vasoconstriction we observed after microtubule depolymerization.
In conclusion, our data support the hypothesis that arteriolar smooth muscle contractile function and arteriolar diameter can be modulated by the state of polymerization of the microtubule network. It may be that cytoskeletal remodeling can provide an additional mechanism for modulating VSM contractile function without a requirement for simultaneously increasing [Ca2+]i. Although the mechanism for this effect remains to be defined, these observations could have significant implications for our understanding of the physiological and pathophysiological regulation of VSM contractile function.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-33324 and HL-55050 to G. A. Meininger and HL-53818 to J. C. Falcone.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and correspondence: G. A. Meininger, Dept. of Medical Physiology, College of Medicine, Texas A&M Univ. Health Science Center, Reynolds Medical Bldg., Rm. 349, College Station, TX 77843-1114 (E-mail: GAM{at}tamu.edu).
Received 15 September 1998; accepted in final form 20 March 1999.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Avila, J.,
and
J. D. Nido.
Control of microtubule polymerization and stability.
Cytoskeleton
1:
47-85,
1995.
2.
Battistella-Patterson, A. S.,
S. Wang,
and
G. L. Wright.
Effect of disruption of the cytoskeleton on smooth muscle contraction.
Can. J. Physiol. Pharmacol.
75:
1287-1299,
1997[Medline].
3.
Danowski, B. A.
Fibroblast contractility and actin organization are stimulated by microtubule inhibitors.
J. Cell Sci.
93:
255-266,
1989
4.
Falcone, J. C.,
M. J. Davis,
and
G. A. Meininger.
Endothelial independence of myogenic response in isolated skeletal muscle arterioles.
Am. J. Physiol.
260 (Heart Circ. Physiol. 29):
H130-H135,
1991
5.
Goodman, A. H.
Un calibreur video simple pour l'utilisation en microscopie video.
Innov. Tech. Biol. Med.
9:
350-356,
1988.
6.
Grynkiewicz, G.,
M. Poenie,
and
R. Y. Tsien.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450,
1985
7.
Ingber, D. E.,
S. Karp,
G. Plopper,
G. Liansen,
and
D. Mooney.
Mechanochemical transduction across extracellular matrix and through the cytoskeleton.
In: Physical Forces and the Mammalian Cell, edited by J. A. Frangos,
and C. L. Ives. San Diego, CA: Academic, 1993, p. 61-78.
8.
Ingber, D. E.
Tensegrity: the architectural basis of cellular mechanotransduction.
Annu. Rev. Physiol.
59:
575-599,
1997[Medline].
9.
Kolodney, M. S.,
and
E. L. Elson.
Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain.
Proc. Natl. Acad. Sci. USA
92:
10252-10256,
1995
10.
Leite, R.,
and
R. C. Webb.
Microtubule disruption potentiates phenylephrine-induced vasoconstriction in rat mesenteric arterial bed.
Eur. J. Pharmacol.
351:
R1-R3,
1998[Medline].
11.
Meininger, G. A.,
D. C. Zaweija,
J. C. Falcone,
M. A. Hill,
and
J. P. Davey.
Calcium measurment in isolated arterioles during myogenic and antagonist stimulation.
Am. J. Physiol.
261 (Heart Circ. Physiol. 30):
H950-H959,
1991
12.
Olmsted, J. B.,
and
M. W. Anders.
Microtubules and microtubule inhibitors.
In: The Cytoskeleton: A Target for Toxic Agents, edited by T. W. Clarkson,
P. R. Sager,
and T. L. M. Syversen. New York: Plenum, 1986, p. 35-53.
13.
Popova, J. S.,
J. C. Garrison,
S. G. Rhee,
and
M. M. Rasenick.
Tubulin, Gq and phosphatidylinositol 4,5-bisphosphate interact to regulate phospholipase C1 signaling.
J. Biol. Chem.
272:
6760-6765,
1997
14.
Rasenick, M. M.,
and
N. Wang.
Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction.
J. Neurochem.
51:
115-130,
1988.
15.
Sheridan, B. C.,
R. C. McIntyre,
D. R. Meldrum,
J. C. Cleveland,
J. Agrafojo,
A. Banerjee,
A. H. Harken,
and
D. A. Fullerton.
Microtubules regulate pulmonary vascular smooth muscle contraction.
J. Surg. Res.
62:
284-287,
1996[Medline].
16.
Tsutsui, H.,
H. Tagawa,
R. L. Kent,
P. L. McCollam,
K. Ishihara,
M. Nagatsu,
and
G. Cooper.
Role of microtubules in contractile dysfunction of hypertrophied cardiocytes.
Circulation
90:
533-555,
1994
17.
Wang, N.
Mechanical interactions among cytoskeletal filaments.
Hypertension
32:
162-165,
1998
18.
Wilson, L.,
and
M. A. Jordan.
Pharmacological probes of microtubule function.
In: Microtubules, edited by J. S. Hyams,
and C. W. Lloyd. New York: Wiley-Liss, 1994, p. 59-83.
19.
Zhou, B.,
and
M. Rabinovitch.
Microtubule involvement in translational regulation of fibronectin expression by light chain 3 of microtubule-associated protein 1 in vascular smooth muscle.
Circ. Res.
83:
481-489,
1998
This article has been cited by other articles:
|
|
 |
|
  L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger The Plastic Nature of the Vascular Wall: A Continuum of Remodeling Events Contributing to Control of Arteriolar Diameter and Structure Physiology, February 1, 2009; 24(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. P. Hilgers and R. C. Webb Molecular Aspects of Arterial Smooth Muscle Contraction: Focus on Rho Exp Biol Med, December 1, 2005; 230(11): 829 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. de Aredes Brum, I. D. G. Duarte, R. C. Webb, and R. Leite Disruption of microtubular network attenuates histamine-induced dilation in rat mesenteric vessels Am J Physiol Cell Physiol, February 1, 2005; 288(2): C443 - C449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hill, S. J. Potocnik, L. A. Martinez-Lemus, and G. A. Meininger Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H849 - H856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Gunst and J. J. Fredberg The first three minutes: smooth muscle contraction, cytoskeletal events, and soft glasses J Appl Physiol, July 1, 2003; 95(1): 413 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lohn, D. Kampf, C. Gui-Xuan, H. Haller, F. C. Luft, and M. Gollasch Regulation of arterial tone by smooth muscle myosin type II Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1383 - C1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Verin, A. Birukova, P. Wang, F. Liu, P. Becker, K. Birukov, and J. G. N. Garcia Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L565 - L574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Wang, K. Naruse, D. Stamenovic', J. J. Fredberg, S. M. Mijailovich, I. M. Tolic'-Norrelykke, T. Polte, R. Mannix, and D. E. Ingber Mechanical behavior in living cells consistent with the tensegrity model PNAS, July 3, 2001; 98(14): 7765 - 7770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sun, A. Huang, S. Sharma, A. Koller, and G. Kaley Endothelial microtubule disruption blocks flow-dependent dilation of arterioles Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2087 - H2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Davis, X. Wu, T. R. Nurkiewicz, J. Kawasaki, G. E. Davis, M. A. Hill, and G. A. Meininger Integrins and mechanotransduction of the vascular myogenic response Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1427 - H1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Paul, P. S. Bowman, and M. S. Kolodney Effects of microtubule disruption on force, velocity, stiffness and [Ca2+]i in porcine coronary arteries Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2493 - H2501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stamenovic, S. M. Mijailovich, I. M. Tolic-Norrelykke, J. Chen, and N. Wang Cell prestress. II. Contribution of microtubules Am J Physiol Cell Physiol, March 1, 2002; 282(3): C617 - C624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. I. Gokina and G. Osol Actin cytoskeletal modulation of pressure-induced depolarization and Ca2+ influx in cerebral arteries Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1410 - H1420. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
